163 related articles for article (PubMed ID: 25013958)
1. Formulation and characterization of acetaminophen nanoparticles in orally disintegrating films.
Al-Nemrawi NK; Dave RH
Drug Deliv; 2016; 23(2):540-9. PubMed ID: 25013958
[TBL] [Abstract][Full Text] [Related]
2. Design of freeze-dried Soluplus/polyvinyl alcohol-based film for the oral delivery of an insoluble drug for the pediatric use.
Shamma R; Elkasabgy N
Drug Deliv; 2016; 23(2):489-99. PubMed ID: 24892631
[TBL] [Abstract][Full Text] [Related]
3. The use of partially hydrolysed polyvinyl alcohol for the production of high drug-loaded sustained release pellets via extrusion-spheronisation and coating: In vitro and in vivo evaluation.
Verstraete G; De Jaeghere W; Vercruysse J; Grymonpré W; Vanhoorne V; Stauffer F; De Beer T; Bezuijen A; Remon JP; Vervaet C
Int J Pharm; 2017 Jan; 517(1-2):88-95. PubMed ID: 27919698
[TBL] [Abstract][Full Text] [Related]
4. Effect of preparation conditions on the size and encapsulation properties of mPEG-PLGA nanoparticles simultaneously loaded with vincristine sulfate and curcumin.
Wang H; Jia Y; Hu W; Jiang H; Zhang J; Zhang L
Pharm Dev Technol; 2013; 18(3):694-700. PubMed ID: 22676257
[TBL] [Abstract][Full Text] [Related]
5. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake.
Sahoo SK; Panyam J; Prabha S; Labhasetwar V
J Control Release; 2002 Jul; 82(1):105-14. PubMed ID: 12106981
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of coprocessed disintegrants produced from tapioca starch and mannitol in orally disintegrating paracetamol tablet.
Adeoye O; Alebiowu G
Acta Pol Pharm; 2014; 71(5):803-11. PubMed ID: 25362809
[TBL] [Abstract][Full Text] [Related]
8. Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb Pro: formulation aspects and nanoparticle stability to nebulization.
Beck-Broichsitter M; Kleimann P; Gessler T; Seeger W; Kissel T; Schmehl T
Int J Pharm; 2012 Jan; 422(1-2):398-408. PubMed ID: 22001839
[TBL] [Abstract][Full Text] [Related]
9. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
Xu H; Zhong H; Liu M; Xu C; Gao Y
Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
[TBL] [Abstract][Full Text] [Related]
10. Effect of polyethylene glycol on preparation of rifampicin-loaded PLGA microspheres with membrane emulsification technique.
Ito F; Fujimori H; Honnami H; Kawakami H; Kanamura K; Makino K
Colloids Surf B Biointerfaces; 2008 Oct; 66(1):65-70. PubMed ID: 18585903
[TBL] [Abstract][Full Text] [Related]
11. On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles.
Packhaeuser CB; Kissel T
J Control Release; 2007 Nov; 123(2):131-40. PubMed ID: 17854938
[TBL] [Abstract][Full Text] [Related]
12. Optimization of PLGA nanoparticles formulation containing L-DOPA by applying the central composite design.
Zhou YZ; Alany RG; Chuang V; Wen J
Drug Dev Ind Pharm; 2013 Feb; 39(2):321-30. PubMed ID: 22607101
[TBL] [Abstract][Full Text] [Related]
13. PVA bio-nanocomposites: a new take-off using cellulose nanocrystals and PLGA nanoparticles.
Rescignano N; Fortunati E; Montesano S; Emiliani C; Kenny JM; Martino S; Armentano I
Carbohydr Polym; 2014 Jan; 99():47-58. PubMed ID: 24274478
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of mucoadhesive buccal patches of flurbiprofen.
Mishra SK; Garud N; Singh R
Acta Pol Pharm; 2011; 68(6):955-64. PubMed ID: 22125962
[TBL] [Abstract][Full Text] [Related]
15. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
Dong Y; Feng SS
Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372
[TBL] [Abstract][Full Text] [Related]
16. Ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) nanoparticles and its antibacterial activity.
Jeong YI; Na HS; Seo DH; Kim DG; Lee HC; Jang MK; Na SK; Roh SH; Kim SI; Nah JW
Int J Pharm; 2008 Mar; 352(1-2):317-23. PubMed ID: 18160236
[TBL] [Abstract][Full Text] [Related]
17. Novel drug delivery devices for providing linear release profiles fabricated by 3DP.
Yu DG; Branford-White C; Ma ZH; Zhu LM; Li XY; Yang XL
Int J Pharm; 2009 Mar; 370(1-2):160-6. PubMed ID: 19118612
[TBL] [Abstract][Full Text] [Related]
18. Development, In Vitro and In Vivo Evaluation of Racecadotril Orodispersible Films for Pediatric Use.
Wang B; Yang L; Wang B; Luo C; Wang Y; Wang H; Chen F; Xiang X
AAPS PharmSciTech; 2021 Jan; 22(1):15. PubMed ID: 33389269
[TBL] [Abstract][Full Text] [Related]
19. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.
Cun D; Jensen DK; Maltesen MJ; Bunker M; Whiteside P; Scurr D; Foged C; Nielsen HM
Eur J Pharm Biopharm; 2011 Jan; 77(1):26-35. PubMed ID: 21093589
[TBL] [Abstract][Full Text] [Related]
20. Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells.
Şengel-Türk CT; Hasçiçek C; Dogan AL; Esendagli G; Guc D; Gönül N
Drug Dev Ind Pharm; 2012 Sep; 38(9):1107-16. PubMed ID: 22348284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
